Navigation Links
The Efficacy Of Newer Stents Questioned

People who undergo a balloon angioplasty to open a clogged artery often receive a stent as well a small, wire-mesh device inserted into the artery// to keep it from closing. The problem with older stents, however, has been that they can trigger an immune response from the cells in the walls of the artery that cause the artery to become occluded.

Stents coated with drugs to stop this process have been touted as the answer to this problem. Researchers after having collected data from 11 studies comparing bare-metal stents with the newer drug-eluting stents say that their results show people who had the drug-eluting stents were significantly less likely than those receiving the bare-metal stents to experience severe cardiac events, 8 percent vs. 16 percent. They were also more likely to avoid an episode of restenosis, or reblocking of the artery, six to 12 months later, a common problem for anyone undergoing balloon angioplasty. Thirty percent of the bare-metal stent patients experienced reblockage compared to just 9 percent of those who got a drug-eluting stent.

The analysis found no difference in mortality rates or subsequent heart attacks in the two groups. However researchers say long term follow-up is needed to fully determine the safety and effectiveness of drug-eluting stents, especially in patients considered at high risk of complications.
'"/>




Page: 1

Related medicine news :

1. Efficacy Of Meningitis C Vaccine
2. The Efficacy Of Allergy Shots Questioned
3. The Efficacy Of Hormone Replacement Therapy Studied
4. Ambiguous Efficacy Of Opioid Drugs In Chronic Inflammatory Joint Pain Relief
5. Efficacy of fish oil supplements in pregnancy.
6. Efficacy of Omega 3 Fatty Acids Needs Wider Perspective
7. Thailand To Test Efficacy Of Stem Cell Technology
8. Efficacy Of Sports-Formulated Jelly Beans In Warding Off Fatigue To Be Studied
9. Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs
10. New Study Shows Efficacy of AROMASIN on Early Breast Cancer
11. KADIAN Efficacy Not Affected by Alcohol Consumption

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The Efficacy Newer Stents Questioned

(Date:11/27/2009)...vehicles may reduce future disease burden, researc...News) -- Encouraging city dwellers to walk and bic...r public health benefits than increased used of lo..., The study compared the projected health effec...narios for London, England, and Delhi, India: bus...
(Date:11/27/2009)...h™ announced today that Spectrum Health (Gra...terprise orthopedic templating solution and its Tr... (PRWEB) November 27, 2009 -- Voyant Hea...rand Rapids, Michigan) has licensed its TraumaCad ...TraumaCad Extend workflow solution, to allow its o...
(Date:11/27/2009)...teractive anatomy education apps from Modality and...ciences learning opportunities for iPhone and iPod...s) November 27, 2009 -- Modality, Inc. and Lippi...Wolters Kluwer Health, today announced the availab...pp Store. Clemente’s Anatomy, Rohen’s ...
(Date:11/26/2009)...Americans living with diabetes will nearly double,...ion in 2034. Over the same period, spending on dia... to $336 billion, even with no increase in the pre...rsity of Chicago report in the December issue of ...tes covered by Medicare will rise from 8.2 million...
(Date:11/26/2009)...otional rollercoaster, study finds , , T...ear factor meets the jubilant sports fan. , A n...ose who root for the winning team -- enjoy the gre...ch and victory was in doubt, producing feelings of...anksgiving weekend as you,re glued to the TV set, ...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
...e-FirstCall/ - The Westaim Corporation,announced t...l western,Canadian construction services companies...posed reorganization agreement dated on,October 3,...hin 14 days of the mailing of the information circ...
... combination that included folic acid and vitamin ...l risk of cancer, including breast cancer, among w...ding to a study in the November 5 issue of JAMA ....fortification of the food supply with folic acid (...
...VION,PHARMACEUTICALS, INC. (OTC Bulletin Board: VI...ference call on Thursday, November 6, 2008 to,disc...e call will begin at 8:30 a.m. Eastern Time., To ... start of the call. When prompted for a pass code,...
...the possibility of,a failed ceasefire and renewed ...us humanitarian situation in the Democratic Republ...carrying out urgently needed,distributions of ther...fighting reignites," said Pierre Willems, Internat...
...n insulin pump to manage diabetes is more convenie...jections. That much, physicians already know. , ...d their primary caregivers is an important questio... lives," says Dr. Max Stachura, director of the Me...
...articipation in Upcoming Investor Conferences in ...O, Nov. 4 Orexigen(R) Therapeutics,Inc. (Nasdaq: ...e treatment,of obesity and other central nervous s...uarter 2008 financial results,as well as upcoming ...
Other Medicine News:Health News:Folic acid, B vitamins do not appear to affect cancer risk 2Health News:Vion Updates Conference Call Information 2Health News:Vion Updates Conference Call Information 3Health News:International Medical Corps Continues Delivering Emergency Relief in Democratic Republic of Congo as Potential for Renewed Fighting Threatens to Deepen Crisis 2Health News:Impact of insulin pump under study 2Health News:Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008 2
(Date:11/27/2009)... ACUO TECHNOLOGIES, developers of h... data migration tools and services, is pleased to ...rk Office has approved a patent application for an...work." Acuo Technologies is pleased to add the U.S.... In general, the granted patent application broad...
(Date:11/25/2009)...5 American Scientific Re...s pleased to announce that they have opened a regi... Shanghai, China. ,, ASR has been able to secur...y for the development and production of current an...nd adults to be distributed and sold globally. Cu...
(Date:11/25/2009)... ERT (Nasdaq: ERES ), a...ompany,s President and CEO, and Keith Schneck, the...cheduled to present at the 21st Annual Piper Jaffr...er 1, 2009 in New York City, New York. ,, Inter...ing the Company,s corporate website at http://www...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 1ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 2ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 3SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 1SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 2Shared Bed May Raise SIDS Risk 59436 1Shared Bed May Raise SIDS Risk 59436 2
...epatitis C and LymphoStat-B(R) for lupus on track ... -,- ABthrax(TM) for inhalation anthrax on track t...hened with investments in oncology portfolio and n... - GSK to advance darapladib to Phase 3 for ath...ome Sciences,Inc. (Nasdaq: HGSI ) today will repo...
... on Updated Results Showing a 20% Reduction in the...t of Disease Free Survival at Five Years, ...EWATER, N.J., May 28 Sanofi-aventis U.S.,announce... (FDA) approved,the supplemental new drug applicat...alysis from the MOSAIC trial in the Eloxatin(R) (o...
Other Medicine Technology:Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 2Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 3Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 4Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 5Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 6Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 7Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 8Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 9Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 10Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 11New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 2New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 3New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 4
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: